Skip to main content
Live · TradingView
Back to the NewsWire

Stocktitan

Published September 11, 2026 · Updated September 12, 2026

Clearmind Enrolls First Patients with Alcohol Use Disorder in CMND-100 Clinical Trial

Read the full story at Stocktitan

psychedelic -derived candidate for AUD. The first two patients were ... press release . Clearmind is not responsible for the contents of third.

Surfaced by 3 Google Alerts

  • Psychedelic press release
  • Psychedelic crime
  • Psychedelic biotech